Selective CB2 Receptor Agonism Protects Central Neurons from Remote Axotomy-Induced Apoptosis through the PI3K/Akt Pathway

Endocannabinoids are neuroprotective in vivo and in vitro, but the mechanisms by which they act are largely unknown. The present study addressed the role of cannabinoid receptors during remote cell death of central neurons in a model that is based on cerebellar lesions. A lesion in one cerebellar hemisphere induced remote cell death and type 2 cannabinoid receptor (CB2R) expression in contralateral precerebellar neurons. Of the selective agonists and antagonists that modulated cannabinoid receptor activity, we found that the CB2R agonist JWH-015 reduced neuronal loss and cytochrome-c release, leading to neurological recovery; these effects were reversed by the selective CB2R antagonist SR144528. Analysis of CB2R-triggered signal transduction demonstrated that in axotomized neurons, CB2R regulated Akt and JNK phosphorylation through a PI3K-dependent pathway, whereas other major signaling routes that are dependent on CB2R, such as ERK1/2 and p38, were not involved. This result was corroborated by the observation that the selective PI3K inhibitor LY294002 blocked the CB2R stimulation effects on neuronal survival as well as Akt and JNK phosphorylation levels. Together, these data demonstrate that axonal damage induces CB2R expression in central neurons and that stimulation of this receptor has a neuroprotective effect that is achieved through PI3K/Akt signaling.

[1]  G. Bernardi,et al.  Methylprednisolone treatment delays remote cell death after focal brain lesion , 2008, Neuroscience.

[2]  Jill M. Wetter,et al.  Differential effects of cannabinoid receptor agonists on regional brain activity using pharmacological MRI , 2008, British journal of pharmacology.

[3]  T. Bisogno,et al.  Endocannabinoids and related compounds: walking back and forth between plant natural products and animal physiology. , 2007, Chemistry & biology.

[4]  S. Nigam,et al.  Biochemistry and pharmacology of endovanilloids. , 2007, Pharmacology & therapeutics.

[5]  D. Centonze,et al.  The endocannabinoid system in targeting inflammatory neurodegenerative diseases. , 2007, Trends in pharmacological sciences.

[6]  G. Uhl,et al.  Discovery of the Presence and Functional Expression of Cannabinoid CB2 Receptors in Brain , 2006, Annals of the New York Academy of Sciences.

[7]  Ken Mackie,et al.  Cannabinoid receptors as therapeutic targets. , 2006, Annual review of pharmacology and toxicology.

[8]  M. Maccarrone Involvement of the Endocannabinoid System in Cancer , 2005 .

[9]  A. Finazzi-Agro’,et al.  Lipid Rafts Control Signaling of Type-1 Cannabinoid Receptors in Neuronal Cells , 2005, Journal of Biological Chemistry.

[10]  F. Block,et al.  Inflammation in areas of remote changes following focal brain lesion , 2005, Progress in Neurobiology.

[11]  N. Rothwell,et al.  Neuroprotective effects of the synthetic cannabinoid HU-210 in primary cortical neurons are mediated by phosphatidylinositol 3-kinase/AKT signaling , 2005, Molecular and Cellular Neuroscience.

[12]  G. Bernardi,et al.  Axotomy dependent purinergic and nitrergic co-expression , 2004, Neuroscience.

[13]  N. Stella Cannabinoid signaling in glial cells , 2004, Glia.

[14]  N. Nonoguchi,et al.  Postischemic Intraventricular Administration of FGF-2 Expressing Adenoviral Vectors Improves Neurologic Outcome and Reduces Infarct Volume after Transient Focal Cerebral Ischemia in Rats , 2004, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[15]  C. Newton,et al.  The cannabinoid system and immune modulation , 2003, Journal of leukocyte biology.

[16]  L. T. McPhail,et al.  In vivo application of mitochondrial pore inhibitors blocks the induction of apoptosis in axotomized neonatal facial motoneurons , 2003, Cell Death and Differentiation.

[17]  M. Maccarrone,et al.  The endocannabinoid system, anandamide and the regulation of mammalian cell apoptosis , 2003, Cell Death and Differentiation.

[18]  M. Yamakuchi,et al.  ASK1–p38 MAPK/JNK signaling cascade mediates anandamide‐induced PC12 cell death , 2003, Journal of neurochemistry.

[19]  J. Girault,et al.  Regulation of Extracellular Signal-Regulated Kinase by Cannabinoids in Hippocampus , 2003, The Journal of Neuroscience.

[20]  P. Knapp,et al.  Activation of the caspase-3 apoptotic cascade in traumatic spinal cord injury , 1999, Nature Medicine.

[21]  R. J. Seitz,et al.  Thalamic metabolism and corticospinal tract integrity determine motor recovery in stroke , 1996, Annals of neurology.

[22]  G. Velasco,et al.  Cannabinoid CB2 receptor: a new target for controlling neural cell survival? , 2007, Trends in pharmacological sciences.

[23]  T. Herdegen,et al.  The JNK and p38 signal transduction following axotomy. , 2001, Restorative Neurology and Neuroscience.

[24]  K. Mackie,et al.  Identification functional characterization of brainstem cannabinoid CB2 receptors. , 2022 .